John Schmidt leads the UK Competition team in London. He has over 25 years of experience dealing with competition authorities and courts in the UK and the EU. He regularly advises on complex competition conduct issues, investigations, litigation, and merger cases with a particular sector focus on the life sciences, consumer goods, and TMT. He is dual-qualified in the UK and Germany with full rights of audience before the European Court of Justice.
John has extensive experience advising pharmaceutical and medical device companies on pricing matters, including a number of reverse payment patent settlement cases both at the EU and UK level as well as investigations into excessive pricing and restrictive agreements in the pharma sector. He also advises on parallel trade and supply chain design, as well as challenging public procurement tenders on behalf of his clients.
Experience
- Bristol-Myers Squibb in its acquisition of Mirati Therapeutics
- Bristol-Myers Squibb in its US$4.1 billion acquisition of Turning Point Therapeutics.
- Boston Scientific in its US$615 million acquisition of Apollo Endosurgery.
- Boston Scientific in relation to its US$1.07 billion acquisition of Lumenis before multiple competition authorities worldwide.
- Wheels Up Experience Inc. in obtaining foreign investment clearances in relation to its proposed acquisition of Air Partner plc.
Perspectives
Recognition
Credentials
Education
- Diploma in Legal Practice, The University of Edinburgh, Edinburgh Law School
- LL.B. (Hons), The University of Edinburgh
Admissions
- Registered Foreign Lawyer, SRA
- Scotland
- Germany
Activities
- Member, Joint Working Party on Competition Law of the Bars and Law Societies
- Member, Law Society of Scotland Competition Law Subcommittee
- Member, Studienvereinigung Kartellrecht
Languages
- German